Aptamer Group, a developer of novel Optimer ® binders to enable innovation in the life sciences sector, says it is gaining commercial momentum as it releases its interim results for the six months ...

The Yorl business said it is now signing multiple new contracts with global market-leading pharmaceutical companies ...

All the latest breaking news on United States. Browse ibtimes archives of photos, videos and articles on United States.

York-based biotech firm, the Aptamer Group, has reported “revenue growth, solid cash position and strong technical progress” in its ...

The company, noted for its novel Optimer® binders to enable innovation ... signing multiple new contracts with global market-leading pharmaceutical companies, many of which represent repeat ...

Mar. 18, 2025 — A research team has found that lecanemab was probably less effective in females than males in its Phase 3 trial. However, there was insufficient evidence to say the drug was ...

However, I think aggressive growth investors might want to consider buying Madrigal Pharmaceuticals' shares. Some analysts project that Rezdiffra could generate peak annual sales of close to $3.5 ...